CN Stock MarketDetailed Quotes

688488 Jiangsu Aidea Pharmaceutical

Watchlist
  • 9.28
  • -0.43-4.43%
Market Closed Nov 15 15:00 CST
3.90BMarket Cap-37419P/E (TTM)

Jiangsu Aidea Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jiangsu Aidea Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
117.81M
--
+87.54%
EPS
--
-0.04
--
--
Analyst Rating
Strong Buy

Nov 16, 2024

Jiangsu Aidea Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency:

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 834.865M--
--2024/FY-- / 508.615M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 834.865M--
--2024/FY-- / 508.615M--
--------
--------
--------

Unlock Free Earnings Estimates

Jiangsu Aidea Pharmaceutical Earnings Reports

  • Eddy Pharmaceuticals: Eddy Pharmaceuticals Third Quarter 2024 Report

    Oct 30 12:00 ET

  • Eddy Pharmaceuticals 2024 Third Quarter Report

    Oct 30 12:00 ET

  • Jiangsu Aidea Pharmaceutical 2024 Half-Year Report

    Aug 22 12:00 ET

  • Summary of jiangsu aidea pharmaceutical's 2024 Interim Report

    Aug 22 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 16, 2024

    Strong Buy

    • Strong Buy

      77.78%

    • Buy

      22.22%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data